HealthEquity Statistics

Total Valuation

HealthEquity has a market cap or net worth of EUR 7.01 billion. The enterprise value is 7.63 billion.

Market Cap	7.01B
Enterprise Value	7.63B

Important Dates

The last earnings date was Wednesday, December 3, 2025.

Earnings Date	Dec 3, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	85.44M
Shares Outstanding	n/a
Shares Change (YoY)	-0.34%
Shares Change (QoQ)	-0.88%
Owned by Insiders (%)	1.86%
Owned by Institutions (%)	106.55%
Float	84.53M

Valuation Ratios

The trailing PE ratio is 42.14 and the forward PE ratio is 21.58.

PE Ratio	42.14
Forward PE	21.58
PS Ratio	6.26
PB Ratio	3.79
P/TBV Ratio	n/a
P/FCF Ratio	19.58
P/OCF Ratio	19.48
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 19.40, with an EV/FCF ratio of 21.30.

EV / Earnings	45.85
EV / Sales	6.89
EV / EBITDA	19.40
EV / EBIT	29.70
EV / FCF	21.30

Financial Position

The company has a current ratio of 4.13, with a Debt / Equity ratio of 0.48.

Current Ratio	4.13
Quick Ratio	3.49
Debt / Equity	0.48
Debt / EBITDA	2.24
Debt / FCF	2.49
Interest Coverage	5.06

Financial Efficiency

Return on equity (ROE) is 9.01% and return on invested capital (ROIC) is 5.83%.

Return on Equity (ROE)	9.01%
Return on Assets (ROA)	5.43%
Return on Invested Capital (ROIC)	5.83%
Return on Capital Employed (ROCE)	9.14%
Revenue Per Employee	359,461
Profits Per Employee	53,425
Employee Count	3,120
Asset Turnover	0.37
Inventory Turnover	n/a

Taxes

In the past 12 months, HealthEquity has paid 47.40 million in taxes.

Income Tax	47.40M
Effective Tax Rate	22.18%

Stock Price Statistics

The stock price has decreased by -10.88% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-10.88%
50-Day Moving Average	82.27
200-Day Moving Average	82.65
Relative Strength Index (RSI)	51.37
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	4.53

Income Statement

In the last 12 months, HealthEquity had revenue of EUR 1.12 billion and earned 166.31 million in profits. Earnings per share was 1.89.

Revenue	1.12B
Gross Profit	757.77M
Operating Income	259.59M
Pretax Income	213.71M
Net Income	166.31M
EBITDA	394.11M
EBIT	259.59M
Earnings Per Share (EPS)	1.89

Full Income Statement

Balance Sheet

The company has 268.13 million in cash and 891.50 million in debt, giving a net cash position of -623.38 million.

Cash & Cash Equivalents	268.13M
Total Debt	891.50M
Net Cash	-623.38M
Net Cash Per Share	n/a
Equity (Book Value)	1.85B
Book Value Per Share	21.61
Working Capital	327.80M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 359.74 million and capital expenditures -1.71 million, giving a free cash flow of 358.03 million.

Operating Cash Flow	359.74M
Capital Expenditures	-1.71M
Free Cash Flow	358.03M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 67.72%, with operating and profit margins of 23.20% and 14.86%.

Gross Margin	67.72%
Operating Margin	23.20%
Pretax Margin	19.10%
Profit Margin	14.86%
EBITDA Margin	35.22%
EBIT Margin	23.20%
FCF Margin	32.00%

Dividends & Yields

HealthEquity does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.34%
Shareholder Yield	0.34%
Earnings Yield	2.37%
FCF Yield	5.11%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HealthEquity has an Altman Z-Score of 4.87 and a Piotroski F-Score of 8.

Altman Z-Score	4.87
Piotroski F-Score	8